Ameliorative effects of aminoguanidine on rat aorta in streptozotocin-induced diabetes and evaluation of α-SMA expression

Anadolu Kardiyoloji Dergisi

Volumn 14, Issue 8, 2014, Pages 679-684

  Elbe, Hülya ^a   Vardı, Nigar ^a   Orman, Doğan ^a   Taşlıdere, Elif ^a   Yıldız, Azibe ^a  

^a INONU UNIVERSITY   (Turkey)

Author keywords

Aminoguanidine; Aorta; Diabetes; Nitric oxide; Rat; smooth muscle actin

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; AMINOGUANIDINE; ACTA2 PROTEIN, MOUSE; ACTIN; ENZYME INHIBITOR; GUANIDINE DERIVATIVE; STREPTOZOCIN;

ADVENTITIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA INJURY; ARTICLE; CONTROLLED STUDY; ELASTIC FIBER; FIBROBLAST; GLUCOSE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MUSCLE ATROPHY; NONHUMAN; PROTEIN EXPRESSION; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TUNICA MEDIA; VASA VASORUM; ANIMAL; AORTA; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; METABOLISM; SPRAGUE DAWLEY RAT;

ACTINS; ANIMALS; AORTA; DIABETES MELLITUS, EXPERIMENTAL; ENZYME INHIBITORS; GUANIDINES; MALE; RATS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN; TUNICA MEDIA;

EID: 84919819085     PISSN: 13028723     EISSN: 13080032     Source Type: Journal    
DOI: 10.5152/akd.2014.5047     Document Type: Article

References (41)

1. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 2002; 23: 599-622. [CrossRef]
2. Stadler K, Jenei V, Somogyi A, Jakus J. Beneficial effects of aminoguanidine on the cardiovascular system of diabetic rats. Diabetes Metab Res Rev 2005; 21: 189-96. [CrossRef]
3. Cüce G, Kalkan SS, Esen HH. Evaluation of TGF beta1 expression and comparison the thickness of different aorta layers in experimental diabetes. Bratisl Lek Listy 2011; 112: 318-22.
4. Vischer UM. Hyperglycemia and the pathogenesis of atherosclerosis: lessons from murine models. Eur J Endocrinol 1999; 140: 1-3. [CrossRef]
5. Suzuki LA, Poot M, Gerrity RG, Bornfeldt KE. Diabetes accelerates smooth muscle accumulation in lesions of atherosclerosis: lack of direct growth-promoting effects of high glucose levels. Diabetes 2001; 50: 851-60. [CrossRef]
6. Stoppa GR, Cesquini M, Roman EA, Ogo SH, Torsoni MA. Aminoguanidine prevented impairment of blood antioxidant system in insulin-dependent diabetic rats. Life Sci 2006; 78: 1352-61. [CrossRef]
7. Dahlfors G, Chen Y, Gustafsson B, Arnqvist HJ. Inhibitory effect of diabetes on proliferation of vascular smooth muscle after ballon injury in rat aorta. Int J Exp Diabetes Res 2000; 1: 101-9. [CrossRef]
8. Skalli O, Pelte MF, Peclet MC, Gabbiani G, Gugliotta P, Bussolati G, et al. Alpha-smooth muscle actin, a differentiation marker of smooth muscle cells, is present in microfilamentous bundles of pericytes. J Histochem Cytochem 1989; 37: 315-21. [CrossRef]
9. Tatsuki R, Satoh K, Yamamoto A, Hoshi K, Ichihara K. Lipid peroxidation in the pancreas and other organs in streptozotocin diabetic rats. Jpn J Pharmacol 1997; 75: 267-73. [CrossRef]
10. Kanter M. Protective effects of thymoquinone on β-cell damage in streptozotocin-induced diabetic rats. Tıp Arastırmaları Dergisi 2009; 7: 64-70.
11. Kanter M, Coşkun O, Korkmaz A, Oter S. Effects of Nigella sativa on oxidative stress and beta-cell damage in streptozotocininduced diabetic rats. Anat Rec A Discow Mol Cell Evol Biol 2004; 279: 685-91. [CrossRef]
12. Coşkun O, Ocakçı A, Bayraktaroğlu T, Kanter M. Exercise training prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas. Tohoku J Exp Med 2004; 203: 145-54. [CrossRef]
13. Traub O, Bibber R. Role of nitric oxide in insulin-dependent diabetes mellitus-related vascular complications. West J Med 1995; 162: 439-45.
14. Ihm SH, Yoo HJ, Park SW, Ihm J. Effect of aminoguanidine on lipid peroxidation in streptozotocin-induced diabetic rats. Metabolism 1999; 48: 1141-5. [CrossRef]
15. Dobsak P, Courderot C, Jancik J, Siedelova J, Svoboda SJ, Sosikova M, et al. Cardioprotective and antiapoptotic effects of aminoguanidine. Scripta Medica 2003; 76: 317-26.
16. Xiao H, Li Y, Qi J, Wang H, Liu K. Peroxynitrite plays a key role in glomerular lesions in diabtic rats. J Nephrol 2009; 22: 800-8.
17. Gürel E, Yılmazer N, Demirci-Tansel C. The effect of aminoguanidine on the kidney of diabetic albino Balb/c mice. IUFS J Biol 2012; 71: 17-29.
18. Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, et al. Diabetes and cardiovascular disease: A statement for healthcare professionals from the American Heart Association. Circulation 1999; 100: 1134-46. [CrossRef]
19. Akgün-Dar K, Bolkent S, Yanardağ R, Tunalı S. Vanadyl sulfate protects against streptozotocin-induced morphological and biochemical changes in rat aorta. Cell Biochem Funct 2007; 25: 603-9. [CrossRef]
20. Lenzen S. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 2008; 51: 216-26. [CrossRef]
21. Liptakova A, Carsky J, Ulicna O, Vancova O, Bozek P, Durackova Z. Influence of beta-resorcylidene aminoguanidine on selected metabolic parameters and antioxidant status of rats with diabetes mellitus. Physiol Res 2002; 51: 277-84.
22. Ünlüçerçi Y, Bekpinar S, Koçak H. Testis glutathione peroxidase and phospholipid hydroperoxide glutathione activities in aminoguanidine-treated diabetic rats. Arch Biochem Biophys 2000; 379: 217-20. [CrossRef]
23. El-Shazly AH, Mahmoud AM, Darwish NS. Potential prophylactic role of aminoguanidine in diabetic retinopathy and nephropathy in experimental animals. Acta Pharm 2009; 59: 67-73. [CrossRef]
24. Oak JH, Youn JY, Cai H. Aminoguanidine inhibits aortic hydrogen peroxide production, VSMC NOX activity and hypercontractility in diabtic mice. Cardiovasc Diabetol 2009; 8: 65. [CrossRef]
25. Astrand H, Rydén-Ahlgren A, Sundkvist G, Sandgren T, Länne T. Reduced aortic wall stress in diabetes mellitus. Eur J Vasc Endovasc Surg 2007; 33: 592-8. [CrossRef]
26. Harrington J, Peña AS, Gent R, Hirte C, Couper J. Aortic intima media thickness is an early marker of atherosclerosis in children with type 1 diabetes mellitus. J Pediatr 2010; 156: 237-41. [CrossRef]
27. Järvisalo MJ, Jartti L, Näntö-Salonen K, Irjala K, Rönnemaa T, Hartiala JJ, et al. Increased aortic intima-media thickness: A marker pf preclinical atherosclerosis in high-risk children. Circulation 2001; 104: 2943-7. [CrossRef]
28. Boyle EM Jr, Lille ST, Allaire E, Clowes AW, Verrier ED. Endothelial cell injury in cardiovascular surgery: Atherosclerosis. Ann Thorac Surg 1997; 63: 885-94. [CrossRef]
29. Vardı N, Öztürk F, Fadıllıoğlu E, Otlu A, Yağmurca M. Histological changes in the rat thoracic aorta after chronic nitric oxide synthase inhibition. Turk J Med Sci 2003; 33: 141-7.
30. Kashiwagi A. Complications of diabetes mellitus and oxidative stress. JMAJ 2001; 44: 521-8.
31. Askari CB, Renard M, Bornfeld KE. Regulation of smooth muscle cell accumulation in diabetes-accelerated atherosclerosis. Histol Histopathol 2002; 17: 1317-28.
32. Kawano M, Koshikawa T, Kanzaki T, Morisaki N, Saito Y, Yoshida S. Diabetes mellitus induces accelerated growth of aortic smooth muscle cells: association with overexpression of PDGF betareceptors. Eur J Clin Invest 1993; 23: 84-90. [CrossRef]
33. Acosta J, Hettinga J, Flückiger R, Krumrei N, Goldfine A, Angarita L, et al. Molecular basis for a link between complement and the vascular complications of diabetes. Proc Natl Acad Sci USA 2000; 97: 5450-5. [CrossRef]
34. Saito Y, Yokote K, Tamura K, Takemoto M, Matsumuto T, Ueno H, et al. Alteration of smooth muscle cell phenotype in diabetic vascular wall: From the molecular point of view. Lipoprotein Metabolism and Atherogenesis 2000.p.235-42.
35. Kanzaki T, Shiina R, Saito Y, Zardi L, Morisaki N. Tranforming growth factor-beta receptor and fibronectin expressions in aortic smooth muscle cells in diabetic rats. Diabetologia 1997; 40: 383-91. [CrossRef]
36. Poulter N. The impact micronized fenofibrate on lipid subfractions and on reaching HDL-target levels in 7,098 patients with dyslipidemia. Br J Cardiol 1999; 6: 682-5.
37. El-Kassaby A, El-Sayed GK, Abdelmawgood A, Ghaly M, Atef I, El-Shawy M. Histological and histochemical vascular changes in experimentally induced diabetic rats. EJHM 2003; 11: 15-29.
38. Ting HH, Timimi FK, Boles KS, Creager SJ, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1996; 97: 22-8. [CrossRef]
39. Nilsson BO. Biological effects of amnioguanidine an uptake. Inflamm Ress 1999; 48: 509-15. [CrossRef]
40. Zhang GL, Wang YH, Teng HL, Lin ZB. Effects of aminoguanidine on nitric oxide production induced by inflammatory cytokines and endotoxin in cultured rat hepatocytes. World J Gastroenterol 2001; 7: 331-4.
41. Rossi MA, Netto CM. Chronic inhibition of NO synthesis per se promotes structural intimal remodelling of the rat aorta. J Hypertens 2001; 19: 1567-79. [CrossRef]